NZ594212A - Method for production of lactoferrin - Google Patents

Method for production of lactoferrin

Info

Publication number
NZ594212A
NZ594212A NZ594212A NZ59421210A NZ594212A NZ 594212 A NZ594212 A NZ 594212A NZ 594212 A NZ594212 A NZ 594212A NZ 59421210 A NZ59421210 A NZ 59421210A NZ 594212 A NZ594212 A NZ 594212A
Authority
NZ
New Zealand
Prior art keywords
lactoferrin
milk
angiogenin
endotoxins
lps
Prior art date
Application number
NZ594212A
Other languages
English (en)
Inventor
Jean-Paul Perraudin
Original Assignee
Jean Paul Perraudin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jean Paul Perraudin filed Critical Jean Paul Perraudin
Publication of NZ594212A publication Critical patent/NZ594212A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79Transferrins, e.g. lactoferrins, ovotransferrins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/30Ion-exchange
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2300/00Processes
    • A23V2300/34Membrane process
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NZ594212A 2009-01-28 2010-01-28 Method for production of lactoferrin NZ594212A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20208809P 2009-01-28 2009-01-28
PCT/IB2010/000149 WO2010112988A1 (en) 2009-01-28 2010-01-28 Method for production of lactoferrin

Publications (1)

Publication Number Publication Date
NZ594212A true NZ594212A (en) 2013-01-25

Family

ID=41818728

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ594212A NZ594212A (en) 2009-01-28 2010-01-28 Method for production of lactoferrin

Country Status (12)

Country Link
US (1) US9115211B2 (https=)
EP (1) EP2391225B1 (https=)
JP (1) JP5718254B2 (https=)
CN (1) CN102348387B (https=)
AU (1) AU2010231075B2 (https=)
CA (1) CA2750701C (https=)
DK (1) DK2391225T3 (https=)
ES (1) ES2805279T3 (https=)
NZ (1) NZ594212A (https=)
PL (1) PL2391225T3 (https=)
RU (1) RU2579661C2 (https=)
WO (1) WO2010112988A1 (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013204850B2 (en) * 2012-10-08 2015-06-25 Murray Goulburn Co-Operative Co. Limited Improved process for purifying milk proteins and products thereof
AU2013204858B2 (en) * 2012-10-08 2015-06-25 Saputo Dairy Australia Pty Limited Improved process for purifying milk proteins and products thereof
RO130063A8 (ro) 2014-08-28 2017-06-30 Romvac Company S.A. Producerea şi utilizarea ovotransferinei moderne ()
WO2016136904A1 (ja) * 2015-02-26 2016-09-01 味の素株式会社 チーズの製造方法及びチーズ改質用の製剤
FR3046603B1 (fr) 2016-01-11 2017-12-29 Michelin & Cie Procede de modification d'un caoutchouc naturel et caoutchouc naturel modifie
US12447166B2 (en) 2016-02-25 2025-10-21 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
US12594285B2 (en) 2016-02-25 2026-04-07 Applied Biological Laboratories, Inc. Compositions and methods for protecting against airborne pathogens and irritants
MX2018010198A (es) 2016-02-25 2019-06-12 Applied Biological Laboratories Inc Composiciones y metodos para proteger contra patogenos e irritantes transportados por el aire.
JP2022513594A (ja) 2018-11-06 2022-02-09 アルヘル プロジェクティランジェ イン インゼニリング ディー.オー.オー. 乳、初乳及び酸性又は甘性ホエーから高度に精製されたラクトフェリン及びラクトペルオキシダーゼを製造する方法
US20230001041A1 (en) 2020-01-30 2023-01-05 Nrl Pharma, Inc. Sanitary product carrying lactoferrin
AU2020203454B1 (en) * 2020-05-26 2021-07-22 HPS Tech Pty Ltd Processing protein
FR3115037B1 (fr) 2020-10-12 2025-02-21 Cie Laitiere Europeenne Procédé de purification de fraction de protéines cationiques et fraction ainsi obtenue
MX2024002323A (es) * 2021-08-23 2024-05-31 Lactea Therapeutics Llc Composiciones de lactoferrina y metodos de uso.
CA3229787A1 (en) * 2021-08-23 2023-03-02 Christopher HLUBB Lactoferrin compositions and methods of use
US20250136666A1 (en) * 2021-11-16 2025-05-01 Noumi Limited A method for producing a lactoferrin powder and uses thereof
DE202023102334U1 (de) 2023-04-28 2023-06-07 Mercurius Production Gmbh Lactoferrin und Vorrichtung zu dessen Herstellung
PL248495B1 (pl) * 2023-05-07 2025-12-22 Polmlek Spolka Z Ograniczona Odpowiedzialnoscia Sposób uzyskiwania laktoferyny w proszku z surowego mleka

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE61701B1 (en) 1986-07-17 1994-11-30 Morinaga Milk Industry Co Ltd Process for producing bovine lactoferrin in high purity
US5571697A (en) * 1989-05-05 1996-11-05 Baylor College Of Medicine Texas Medical Center Expression of processed recombinant lactoferrin and lactoferrin polypeptide fragments from a fusion product in Aspergillus
JP2686831B2 (ja) * 1989-09-22 1997-12-08 雪印乳業株式会社 鉄結合性蛋白質を分離、精製し、採取する方法
US6096870A (en) * 1994-01-05 2000-08-01 Sepragen Corporation Sequential separation of whey
ATE209862T1 (de) * 1994-02-16 2001-12-15 Pharming Intellectual Pty Bv Isolierung von lactoferrin aus milch
JPH08217693A (ja) * 1995-02-17 1996-08-27 Yoshihisa Naito 新規医薬組成物
JP2974604B2 (ja) * 1996-01-23 1999-11-10 雪印乳業株式会社 塩基性タンパク質組成物、塩基性ペプチド組成物及びその利用
JPH1059864A (ja) * 1996-08-15 1998-03-03 Morinaga Milk Ind Co Ltd 経口がん転移抑制剤
JP2002326950A (ja) * 2001-05-02 2002-11-15 Meiji Milk Prod Co Ltd 炎症性サイトカイン産生抑制剤
US20030096736A1 (en) * 2001-05-09 2003-05-22 Kruzel Marian L. Lactoferrin for age related disorders in humans
CN100467059C (zh) * 2002-05-10 2009-03-11 阿根尼克斯有限公司 乳铁蛋白在治疗恶性肿瘤疾病中的用途
US7238661B2 (en) * 2002-05-24 2007-07-03 Agennix, Inc. Oral lactoferrin in the treatment of respiratory disorders
EP1712558A4 (en) * 2004-02-03 2007-02-21 Univ Kurume PROCESS FOR SEPARATION / PURIFICATION OF CATIONIC PROTEIN
US20090306350A1 (en) * 2005-05-13 2009-12-10 Crea Biopharma Inc. New purification method of lactoferrin
JP5087297B2 (ja) * 2007-03-05 2012-12-05 森永乳業株式会社 インターロイキン−11産生促進剤
CN101117351B (zh) * 2007-04-30 2010-08-18 北京济普霖生物技术有限公司 一种从转基因牛乳中纯化重组人乳铁蛋白的方法
US7919589B2 (en) * 2007-07-10 2011-04-05 Glanbia Nutritionals (Ireland), Ltd. Method for removing endotoxin from proteins

Also Published As

Publication number Publication date
WO2010112988A1 (en) 2010-10-07
CN102348387A (zh) 2012-02-08
RU2011135536A (ru) 2013-03-10
ES2805279T3 (es) 2021-02-11
AU2010231075A1 (en) 2011-08-18
JP5718254B2 (ja) 2015-05-13
PL2391225T3 (pl) 2020-11-16
CN102348387B (zh) 2014-12-31
EP2391225A1 (en) 2011-12-07
US20110301077A1 (en) 2011-12-08
AU2010231075B2 (en) 2015-06-11
CA2750701A1 (en) 2010-10-07
US9115211B2 (en) 2015-08-25
EP2391225B1 (en) 2020-05-06
DK2391225T3 (da) 2020-07-20
JP2012516319A (ja) 2012-07-19
RU2579661C2 (ru) 2016-04-10
CA2750701C (en) 2018-02-13

Similar Documents

Publication Publication Date Title
NZ594212A (en) Method for production of lactoferrin
EP2464599B1 (en) Fractionation of a waste liquor stream from nanocrystalline cellulose production
MX353173B (es) Queso y su preparacion.
NZ595765A (en) Isolation and purification of components of whey
NZ595764A (en) Whey or raw milk demineralisation and fractionation
EP2036858A3 (en) Method for purifying chlorosilanes
MX2012004851A (es) Purificacion de sacaridos capsulares de staphylococcus aureus tipo 5 y tipo 8.
WO2011049991A3 (en) Milk protein concentrates
RU2014104031A (ru) Композиция на основе молока
WO2008090854A1 (ja) 逆浸透膜処理方法
CN103709246A (zh) 一种乳铁蛋白及乳过氧化物酶的纯化方法
NZ598888A (en) Method for manufacturing low-phosphorus whey
BRPI0701649A (pt) método de produção de um queijo processado, queijo processado, e método de modificação de soro de leite
SE0100801L (sv) Metod för förbehandling av mjölk vid mikrofiltrering
CN106086091A (zh) 一种衣康酸浓缩冷凝水用于衣康酸发酵的方法
LT2014027A (lt) Jogurtas 1,5 % riebumo, pagamintas iš rekombinuoto pieno, ir jo gamybos būdas
CN110655570B (zh) 一种制备具有所需铁饱和度的乳铁蛋白的方法
LT2014017A (lt) Tepamas 14 % riebumo sūris iš rekombinuoto pieno ir jo gamybos būdas
LT2014021A (lt) Rekombinuotas 3,5 % riebumo, sterilizuotas pienas ir jo gamybos būdas
LT2014028A (lt) Ilgo laikymo jogurto gėrimas 1,4 % riebumo ir jo gamybos būdas
LT2014016A (lt) Rekombinuotas, pasterizuotas 0,5% riebumo pienas ir jo gamybos būdas
Murtuza et al. Assay of BLf using sandwich elisa and its comparative study of holstein-friesian crossbred and Sahiwal with Poda Thurpu cow milk
LT2014025A (lt) Rekombinuotas 3,5 % riebumo, pasterizuotas pienas ir jo gamybos būdas
SU116101A1 (ru) Способ очистки диффузионного сока в свеклосахарном производстве
LT2014036A (lt) Rekombinuotas kondensuotas 26,5 % tirštumo pienas, apdorotas ypač aukštoje temperatūroje, ir jo gamybos būdas

Legal Events

Date Code Title Description
ERR Error or correction

Free format text: THE POSTPONEMENT PERIOD HAS BEEN CORRECTED TO 0

Effective date: 20130103

PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 28 JAN 2017 BY DENNEMEYER SA

Effective date: 20131218

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2018 BY DENNEMEYER + CO

Effective date: 20161223

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2019 BY DENNEMEYER + CO

Effective date: 20171216

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2020 BY DENNEMEYER + CO

Effective date: 20190110

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2021 BY DENNEMEYER+CO.

Effective date: 20200111

RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 28 JAN 2022 BY DENNEMEYER + CO.

Effective date: 20210125

LAPS Patent lapsed